Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Effectiveness and Treatment Patterns of Upadacitinib in Monotherapy or Used in Combination With Methotrexate in Active Psoriatic Arthritis Patients

NCT05616871 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05616871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05616871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Effectiveness and Treatment Patterns of Upadacitinib in Monotherapy or Used in Combination With Methotrexate in Active Psoriatic Arthritis Patients
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
December 15, 2022
Completion date
June 11, 2026
Enrollment
464 (actual)
Sites
89

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis